TWA
KYNB

TCI Wealth Advisors’s Kyntra Bio KYNB Stock Holding History

TCI Wealth Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20
Closed -$9.26K – 916
2023
Q1 		$9.26K Buy
+20
New +$10.6K ﹤0.01% 1139
2022
Q2 		– Sell
-20
Closed -$6K – 2346
2022
Q1 		$6K Hold
20
– – ﹤0.01% 1413
2021
Q4 		$7K Buy
20
+7
+54% +$2.18K ﹤0.01% 1415
2021
Q3 		$3K Buy
13
+2
+18% +$709 ﹤0.01% 1930
2021
Q2 		$7K Buy
+11
New +$6.34K ﹤0.01% 1198

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCI Wealth Advisors's KYNB Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 20 shares — an estimated $9.26K sold.

TCI Wealth Advisors first reported a position in KYNB in Q2 2021 and held it in 5 quarters. The position peaked at $9.26K in Q1 2023. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 20 Kyntra Bio shares in Q2 2023, an estimated $9.26K.
  • TCI Wealth Advisors first reported a position in Kyntra Bio in Q2 2021 and held it in 5 quarters.
  • TCI Wealth Advisors's Kyntra Bio position peaked at $9.26K in Q1 2023.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.